A Phase 1, Cross-Over, Single-Dose, Open-Label Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 04 Mar 2010
At a glance
- Drugs PF 4620110 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Pfizer
- 04 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 04 Mar 2010 Last checked against ClinicalTrials.gov record.
- 19 Feb 2010 New trial record